Ginkgetin induced autophagic cell death in non-small cell lung cancer (NSCLC) A549 cells, which was inhibited by the autophagosome formation blocker 3-methyladenine; ginkgetin treatment also increased autophagy marker LC3 I/II and decreased p62 [54]. Here, MAP1LC3A is linked to non-small cell lung carcinoma.